(Q48703134)

English

The potential for bias in reporting of industry-sponsored clinical trials.

scientific article published in January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

The potential for bias in reporting of industry-sponsored clinical trials. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

1 reference

based on heuristic

inferred from title

author name string

Stephen Pyke

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

Steven A Julious

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

Simon Day

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

Michael O'Kelly

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

Susan Todd

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

James Matcham

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

Jorgen Seldrup

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

publication date

1 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

Pharmaceutical Statistics

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

10

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

74-79

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies.

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Reporting financial conflicts of interest and relationships between investigators and research sponsors.

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Sponsorship, Authorship, and Accountability

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Impact of covert duplicate publication on meta-analysis: a case study

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Publication bias: evidence of delayed publication in a cohort study of clinical research projects

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

JAMA's policy on industry sponsored studies

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Fair conduct and fair reporting of clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Extra scrutiny for industry funded trials.

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Clinical attrition due to biased preclinical assessments of potential efficacy.

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Contradicted and initially stronger effects in highly cited clinical research

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Are these data real? Statistical methods for the detection of data fabrication in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Selective reporting in clinical trials: analysis of trial protocols accepted by The Lancet

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Ghost authorship in industry-initiated randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Industry funding and the reporting quality of large long-term weight loss trials.

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation

1 reference

https://api.crossref.org/works/10.1002%2FPST.429

21 January 2018

Identifiers

10.1002/PST.429

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21275037

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48703134&oldid=1245155619"